Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials (vol 38, pg 742, 2017)

被引：0
|
作者：
不详
机构：
来源：
EUROPEAN HEART JOURNAL | 2018年 / 39卷 / 16期
基金：
英国医学研究理事会;
关键词：
D O I：
10.1093/eurheartj/ehx277
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1403 / 1403
页数：1
相关论文
共 50 条
  • [1] Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials
    Abdul-Rahim, Azmil H.
    Perez, Ana-Cristina
    MacIsaac, Rachael L.
    Jhund, Pardeep S.
    Claggett, Brian L.
    Carson, Peter E.
    Komajda, Michel
    McKelvie, Robert S.
    Zile, Michael R.
    Swedberg, Karl
    Yusuf, Salim
    Pfeffer, Marc A.
    Solomon, Scott D.
    Lip, Gregory Y. H.
    Lees, Kennedy R.
    McMurray, John J. V.
    EUROPEAN HEART JOURNAL, 2017, 38 (10) : 742 - 750
  • [2] What Have We Learned About Patients With Heart Failure and Preserved Ejection Fraction From DIG-PEF, CHARM-Preserved, and I-PRESERVE?
    Campbell, Ross T.
    Jhund, Pardeep S.
    Castagno, Davide
    Hawkins, Nathaniel M.
    Petrie, Mark C.
    McMurray, John J. V.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (23) : 2349 - 2356
  • [3] Risk of Clinical Outcomes and Baseline Atrial Fibrillation: Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial
    Oluleye, Oludamilola
    Win, Sithu
    Rector, Thomas
    Komadja, Michel
    Zile, Michael
    Mckelvie, Robert
    McMurray, John
    Massie, Barry
    Carson, Peter
    Anand, Inderjit
    CIRCULATION, 2013, 128 (22)
  • [4] Predicting Stroke in Heart Failure and Preserved Ejection Fraction Without Atrial Fibrillation
    Kondo, Toru
    Jering, Karola S.
    Jhund, Pardeep S.
    Anand, Inder S.
    Desai, Akshay S.
    Lam, Carolyn S. P.
    Maggioni, Aldo P.
    Martinez, Felipe A.
    Packer, Milton
    Petrie, Mark C.
    Pfeffer, Marc A.
    Redfield, Margaret M.
    Rouleau, Jean L.
    van Veldhuisen, Dirk J.
    Zannad, Faiez
    Zile, Michael R.
    Solomon, Scott D.
    McMurray, John J. V.
    CIRCULATION-HEART FAILURE, 2023, 16 (07) : E010377
  • [5] PREDICTING STROKE IN HEART FAILURE AND PRESERVED EJECTION FRACTION WITHOUT ATRIAL FIBRILLATION
    Kondo, Toru
    Jering, Karola
    Jhund, Pardeep
    Anand, Inderjit S.
    Desai, Akshay S.
    Lam, Carolyn S. P.
    Maggioni, Aldo Pietro
    Martinez, Felipe A.
    Packer, Milton
    Petrie, Mark
    Pfeffer, Marc A.
    Eld, Margaret M. Redfi
    Rouleau, Jean L.
    van Veldhuisen, Dirk J.
    Zannad, Faiez
    Zile, Michael R.
    Solomon, Scott D.
    McMurray, John J. V.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 305 - 305
  • [6] Mode of death in patients with heart failure and a preserved ejection fraction: results from irbesartan heart failure with preserved ejection fraction study (I-Preserve) trial
    Zile, M. R.
    Gaasch, W. H.
    Anand, I.
    Haass, M.
    Little, W. C.
    Miller, A.
    Lopez-Sendon, J.
    Teerlink, J. R.
    White, M.
    Carson, P. E.
    EUROPEAN HEART JOURNAL, 2009, 30 : 867 - 867
  • [7] Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) Trial
    Zile, Michael R.
    Gaasch, William H.
    Anand, Inder S.
    Haass, Markus
    Little, William C.
    Miller, Alan B.
    Lopez-Sendon, Jose
    Teerlink, John R.
    White, Michel
    McMurray, John J.
    Komajda, Michel
    McKelvie, Robert
    Ptaszynska, Agata
    Hetzel, Scott J.
    Massie, Barry M.
    Carson, Peter E.
    CIRCULATION, 2010, 121 (12) : 1393 - 1405
  • [8] Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction:: the CHARM-Preserved Trial
    Yusuf, S
    Pfeffer, MA
    Swedberg, K
    Granger, CB
    Held, P
    McMurray, JJV
    Michelson, EL
    Olofsson, B
    Östergren, J
    LANCET, 2003, 362 (9386): : 777 - 781
  • [9] Why Are patients With Heart Failure and Preserved Ejection Fraction Hospitalized? Data From I-PRESERVE
    Carson, Peter
    Anand, Inder
    Win, Sithu
    Zile, Michael
    Haas, Markus
    Little, William
    Miller, Alan
    Lopez-Sendon, Jose
    Teerlink, John
    White, Michel
    Komajda, Michel
    McKelvie, Robert S.
    McMurray, John J.
    Massie, Barry
    CIRCULATION, 2013, 128 (22)
  • [10] Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients With Heart Failure and Preserved Ejection Fraction The Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial
    Lam, Carolyn S. P.
    Carson, Peter E.
    Anand, Inder S.
    Rector, Thomas S.
    Kuskowski, Michael
    Komajda, Michel
    McKelvie, Robert S.
    McMurray, John J.
    Zile, Michael R.
    Massie, Barry M.
    Kitzman, Dalane W.
    CIRCULATION-HEART FAILURE, 2012, 5 (05) : 571 - 578
12345